InflaRx NV (IFRX)
2.06
+0.02
(+0.98%)
USD |
NASDAQ |
Nov 21, 16:00
2.10
+0.04
(+1.94%)
After-Hours: 20:00
InflaRx Revenue (Quarterly): 0.1362M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.1362M |
June 30, 2024 | 0.0068M |
March 31, 2024 | 0.0391M |
Date | Value |
---|---|
December 31, 2023 | 0.0025M |
September 30, 2023 | 0.0662M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0025M
Minimum
Dec 2023
0.1362M
Maximum
Sep 2024
0.0502M
Average
0.0391M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
Affimed NV | 0.1705M |
BioNTech SE | 1.369B |
Immatics NV | 55.61M |
CureVac NV | 543.20M |
ATAI Life Sciences NV | 0.04M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -19.19M |
Total Expenses (Quarterly) | 17.03M |
EPS Diluted (Quarterly) | -0.3299 |
Enterprise Value | 56.64M |
Profit Margin (Quarterly) | -14.09K% |
Earnings Yield | -52.16% |
Normalized Earnings Yield | -48.90 |